This company has been marked as potentially delisted and may not be actively trading. Novus Therapeutics (NVUS) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock NVUS vs. NNVC, BIVI, UBX, EDSA, LPCN, QNTM, MIRA, CMMB, BFRG, and IMNNShould you be buying Novus Therapeutics stock or one of its competitors? The main competitors of Novus Therapeutics include NanoViricides (NNVC), BioVie (BIVI), Unity Biotechnology (UBX), Edesa Biotech (EDSA), Lipocine (LPCN), Quantum Biopharma (QNTM), MIRA Pharmaceuticals (MIRA), Chemomab Therapeutics (CMMB), Bullfrog AI (BFRG), and Imunon (IMNN). These companies are all part of the "medical" sector. Novus Therapeutics vs. NanoViricides BioVie Unity Biotechnology Edesa Biotech Lipocine Quantum Biopharma MIRA Pharmaceuticals Chemomab Therapeutics Bullfrog AI Imunon NanoViricides (NYSE:NNVC) and Novus Therapeutics (NASDAQ:NVUS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their community ranking, valuation, institutional ownership, risk, earnings, analyst recommendations, dividends, media sentiment and profitability. Is NNVC or NVUS more profitable? NanoViricides' return on equity of -87.90% beat Novus Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets NanoViricidesN/A -87.90% -78.69% Novus Therapeutics N/A -133.49%-30.52% Does the media prefer NNVC or NVUS? In the previous week, NanoViricides had 1 more articles in the media than Novus Therapeutics. MarketBeat recorded 1 mentions for NanoViricides and 0 mentions for Novus Therapeutics. NanoViricides' average media sentiment score of 1.00 beat Novus Therapeutics' score of 0.00 indicating that NanoViricides is being referred to more favorably in the media. Company Overall Sentiment NanoViricides Positive Novus Therapeutics Neutral Which has more volatility & risk, NNVC or NVUS? NanoViricides has a beta of 1.14, indicating that its share price is 14% more volatile than the S&P 500. Comparatively, Novus Therapeutics has a beta of 2.07, indicating that its share price is 107% more volatile than the S&P 500. Does the MarketBeat Community prefer NNVC or NVUS? Novus Therapeutics received 252 more outperform votes than NanoViricides when rated by MarketBeat users. Likewise, 66.84% of users gave Novus Therapeutics an outperform vote while only 0.00% of users gave NanoViricides an outperform vote. CompanyUnderperformOutperformNanoViricidesOutperform VotesNo VotesUnderperform Votes57100.00% Novus TherapeuticsOutperform Votes25266.84% Underperform Votes12533.16% Do insiders and institutionals have more ownership in NNVC or NVUS? 10.3% of NanoViricides shares are held by institutional investors. 4.6% of NanoViricides shares are held by company insiders. Comparatively, 2.2% of Novus Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has better earnings and valuation, NNVC or NVUS? NanoViricides is trading at a lower price-to-earnings ratio than Novus Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNanoViricidesN/AN/A-$8.29M-$0.72-1.58Novus TherapeuticsN/AN/A-$16.01M-$21.58-0.15 SummaryNanoViricides beats Novus Therapeutics on 7 of the 12 factors compared between the two stocks. Remove Ads Get Novus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NVUS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVUS vs. The Competition Export to ExcelMetricNovus TherapeuticsPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.75M$6.73B$5.54B$7.49BDividend YieldN/A2.79%5.35%4.04%P/E Ratio-0.156.9923.2518.07Price / SalesN/A198.59361.2686.81Price / CashN/A65.6738.1634.64Price / Book0.255.926.493.99Net Income-$16.01M$142.37M$3.21B$247.18M Novus Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NVUSNovus TherapeuticsN/A$3.31+2.8%N/A+61.8%$4.75MN/A-0.157High Trading VolumeNNVCNanoViricidesN/A$1.17-3.3%N/A-9.4%$18.30MN/A-1.6220Positive NewsGap DownBIVIBioVie2.3297 of 5 stars$0.98-3.0%$3.00+206.1%+81.3%$18.08MN/A-0.1010Short Interest ↓News CoverageGap DownUBXUnity Biotechnology4.0003 of 5 stars$1.04-8.8%$5.33+412.8%-34.2%$17.54M$240,000.00-0.7960Gap DownHigh Trading VolumeEDSAEdesa Biotech2.5537 of 5 stars$2.44-2.4%$21.00+760.7%-44.3%$17.06MN/A-1.3020LPCNLipocine1.4773 of 5 stars$3.18-3.0%$10.00+214.5%-36.2%$17.01M$11.20M-4.1810QNTMQuantum BiopharmaN/A$7.71-9.9%N/AN/A$16.43MN/A-0.50N/AEarnings ReportGap DownMIRAMIRA Pharmaceuticals1.9286 of 5 stars$0.98-7.5%$14.00+1,328.6%-11.4%$16.23MN/A-1.752Earnings ReportUpcoming EarningsShort Interest ↑Analyst RevisionCMMBChemomab Therapeutics3.3823 of 5 stars$1.09-3.5%$9.00+725.7%+47.7%$15.65MN/A-1.0920Gap DownBFRGBullfrog AI0.5434 of 5 stars$1.65-2.9%N/A-44.8%$15.54M$60,000.00-1.944Upcoming EarningsGap DownIMNNImunon1.8969 of 5 stars$1.05-3.7%$21.50+1,947.6%-40.0%$15.35M$500,000.00-0.5630 Remove Ads Related Companies and Tools Related Companies NNVC Alternatives BIVI Alternatives UBX Alternatives EDSA Alternatives LPCN Alternatives QNTM Alternatives MIRA Alternatives CMMB Alternatives BFRG Alternatives IMNN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NVUS) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NVUS Stock Free NVUS Stock Alerts